1. Mozaheb Z. Epidemiology of Lymphoid Malignancy in Asia: Intech; 2012. |
|
2. Boffetta P. I. Epidemiology of adult non-Hodgkin lymphoma. Annals of oncology. 2011;22(suppl 4):iv27-iv31. [DOI via Crossref] |
|
3. Engels EA. Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiology Biomarkers & Prevention. 2007;16(3):401-4. [DOI via Crossref] [Pubmed] |
|
4. Foss FM, Zinzani PL, Vose JM, Gascoyne RD, Rosen ST, Tobinai K. Peripheral T-cell lymphoma. Blood. 2011;117(25):6756-67. [DOI via Crossref] [Pubmed] |
|
5. Harris ME. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124-30. [DOI via Crossref] [Pubmed] |
|
6. Tajima K. The 4th nationâwide study of adult Tâcell leukemia/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographical and clinical features. International Journal of Cancer. 1990;45(2):237-43. [DOI via Crossref] [Pubmed] |
|
7. Abbaszadegan MR, Gholamin M, Tabatabaee A, Farid R, Houshmand M, Abbaszadegan M. Prevalence of human Tlymphotropic virus type 1 among blood donors from Mashhad, Iran. Journal of clinical microbiology. 2003;41(6):2593-5. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|
8. Mozaheb Z, Aledavood A, Farzad F. Distributions of major subtypes of lymphoid malignancies among adults in Mashhad, Iran. Cancer Epidemiology. 2011;35(1):26-9. [DOI via Crossref] [Pubmed] |
|
9. Ohshima K, Suzumiya J, Kikuchi M. The World Health Organization classification of malignant lymphoma: Incidence and clinical prognosis in HTLVâ1âendemic area of Fukuoka. Pathology international. 2002;52(1):1-12. [DOI via Crossref] [Pubmed] |
|
10. De Th� G, Bomford R. An HTLV-I vaccine: why, how, for whom? AIDS research and human retroviruses. 1993;9(5):381-6. [DOI via Crossref] |
|
11. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita K-I, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proceedings of the National Academy of Sciences. 1981;78(10):6476-80. [DOI via Crossref] |
|
12. Morgan OS, Mora C, Rodgers-Johnson P, Char G. HTLV-1 and polymyositis in Jamaica. The Lancet. 1989;334(8673):1184-7. [DOI via Crossref] |
|
13. Tarhini M, Kchour G, Zanjani DS, Rafatpanah H, Otrock ZK, Bazarbachi A, et al. Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran. Pathology. 2009;41(5):498-9. [DOI via Crossref] [Pubmed] |
|
14. Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Frontiers in microbiology. 2012;3:388. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|
15. Mueller N, Okayama A, Stuver S, Tachibana N. Findings from the Miyazaki cohort study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 1996;13:S2-S7. [DOI via Crossref] |
|
16. Yamaguchi K. Human T-lymphotropic virus type I in Japan. The Lancet. 1994;343(8891):213-6. [DOI via Crossref] |
|
17. Kakuda K, Ikematsu H, Chong WLY, Hayashi J, Kashiwagi S. Molecular epidemiology of human T lymphotropic virus type 1 transmission in Okinawa, Japan. The American journal of tropical medicine and hygiene. 2002;66(4):404-8. [Pubmed] |
|
18. Gessain A, Gallo RC, Franchini G. Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. Journal of virology. 1992;66(4):2288-95. [Pubmed] [PMC Free Fulltext] |
|
19. Liu L, Buchner E, Beitze D, Schmidt-Weber CB, Kaever V, Emmrich F, et al. Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. International journal of immunopharmacology. 1996;18(10):529-43. [DOI via Crossref] |
|
20. Nerurkar VR, Song K-J, Saitou N, Melland RR, Yanagihara R. Interfamilial and intrafamilial genomic diversity and molecular phylogeny of human T-cell lymphotropic virus type I from Papua New Guinea and the Solomon Islands. Virology. 1993;196(2): 506-13. [DOI via Crossref] [Pubmed] |
|
21. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult Tâcell leukaemiaâlymphoma. British journal of haematology. 1991;79(3):428-37. [DOI via Crossref] [Pubmed] |
|
22. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50(3):481-92. [Pubmed] |
|
23. Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058-68. [DOI via Crossref] [Pubmed] |
|
24. Mozaheb Z. Rare Presentation of Anaplastic Large Cell Lymphoma and HTLV1 Positivity: A Case Report and Review. Jacobs Journal of Hematology. 2015;1(3):16. |
|
25. Gill PS, Harrington Jr W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, et al. Treatment of adult T-cell leukemia�lymphoma with a combination of interferon alfa and zidovudine. New England Journal of Medicine. 1995;332(26):1744-8. [DOI via Crossref] [Pubmed] |
|
26. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. Journal of Clinical Oncology. 2009;27(3):453-9. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] |
|